Χώρα: Νέα Ζηλανδία
Γλώσσα: Αγγλικά
Πηγή: Medsafe (Medicines Safety Authority)
Finasteride 1mg
Organon (New Zealand) Limited
Finasteride 1 mg
1 mg
Film coated tablet
Active: Finasteride 1mg Excipient: Docusate sodium Hyprolose Hypromellose Iron oxide red Iron oxide yellow Lactose monohydrate Magnesium stearate Microcrystalline cellulose Purified talc Sodium starch glycolate Starch Titanium dioxide
Blister pack, cold-formed aluminium, 28 tablets
Prescription
Prescription
F.I.S. Fabbrica Italiana Sintetici SpA
Package - Contents - Shelf Life: Blister pack, cold-formed aluminium - 28 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, cold-formed aluminium - 84 tablets - 36 months from date of manufacture stored at or below 30°C - Bottle, plastic, - - 36 months from date of manufacture stored at or below 30°C - Tablet container, medistick - - 36 months from date of manufacture stored at or below 30°C
1997-01-14
PROPECIA ® _finasteride _ 1 mg tablet WHAT IS IN THIS LEAFLET This leaflet answers some common questions about PROPECIA. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking PROPECIA against the benefits they expect it will have for you. If you have any concerns about taking this medicine, ask your doctor or pharmacist. Keep this leaflet with the medicine. You may need to read it again. WHAT PROPECIA IS USED FOR PROPECIA is for use by men only. PROPECIA is used to treat men with male pattern hair loss to increase hair growth on the scalp and to prevent further hair loss. Male pattern hair loss (also known as androgenetic alopecia) is a common condition in which men experience thinning of the hair on the scalp. This often results in a receding hair line and/or balding on the top of the head. These changes typically start to occur in some men in their 20s and become more common with age. Once hair loss has occurred over a long period of time, the hair may be permanently lost. Male pattern hair loss is thought to be caused by a combination of family history (heredity) and production of a particular male hormone, called dihydrotestosterone (DHT). Men with male pattern hair loss have more DHT in the balding part of their scalp than in other parts, resulting in increased hair loss. HOW PROPECIA WORKS PROPECIA specifically lowers the levels of DHT in the scalp, thus helping to reverse the balding process. PROPECIA does not affect hair on other parts of the body. Men with mild to moderate, but not complete, hair loss can expect to benefit from the use of PROPECIA. In women who were studied PROPECIA was not effective in the treatment of hair loss (androgenetic alopecia). There should be no need to change your usual hair care routine (for example, shampooing or haircuts) because you are taking PROPECIA. PROPECIA is not addictive. BEFORE YOU TAKE PROPECIA WHEN YOU MUST NOT Διαβάστε το πλήρες έγγραφο
NEW ZEALAND DATA SHEET Page 1 1 PRODUCT NAME PROPECIA ® finasteride 1 mg film coated tablet 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet of PROPECIA contains 1 mg of finasteride. Excipients with known effect: lactose monohydrate For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM A tan octagonal convex film coated tablet embossed with a P logo on one side and PROPECIA on the other. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS • PROPECIA is indicated for the treatment of men with male pattern hair loss (androgenetic alopecia) to increase hair growth and prevent further hair loss. • PROPECIA is NOT indicated for use in women (see section 4.6 Fertility, pregnancy and lactation, _Pregnancy_) or children. PROPECIA is not effective in postmenopausal women with androgenetic alopecia. 4.2 DOSE AND METHOD OF ADMINISTRATION The recommended dosage is one 1 mg tablet daily. PROPECIA may be taken with or without food. In general, daily use for 3 months or more is necessary before increased hair growth and/or prevention of further hair loss is observed. Continued use is recommended to obtain maximum benefit. Withdrawal from the treatment leads to reversibility of effect within 12 months. 4.3 CONTRAINDICATIONS PROPECIA is contraindicated in the following: • Use in women when they are or may potentially be pregnant (See section 4.6 Fertility, pregnancy and lactation, _Pregnancy_). • Hypersensitivity to any component of this product. • PROPECIA is not indicated for use in women or children. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE In clinical studies with PROPECIA in men 18-41 years of age, the mean value of serum prostate-specific antigen (PSA) decreased from 0.7 ng/mL at baseline to 0.5 ng/mL at Month 12. When PROPECIA is used for treatment of male pattern hair loss in older men who also NEW ZEALAND DATA SHEET Page 2 have benign prostatic hyperplasia (BPH), consideration should be given to the fact that, in older men with BPH, PSA levels are decreased by approximatel Διαβάστε το πλήρες έγγραφο